These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 20090448)
1. Inhomogeneous bone marrow uptake caused by G-CSF mimics multiple bone metastases on FDG-PET. Nakamoto Y; Suga T; Hara T; Ishizu K; Togashi K Clin Nucl Med; 2010 Feb; 35(2):74-6. PubMed ID: 20090448 [TBL] [Abstract][Full Text] [Related]
2. Preclinical and clinical studies of bone marrow uptake of fluorine-1-fluorodeoxyglucose with or without granulocyte colony-stimulating factor during chemotherapy. Sugawara Y; Fisher SJ; Zasadny KR; Kison PV; Baker LH; Wahl RL J Clin Oncol; 1998 Jan; 16(1):173-80. PubMed ID: 9440740 [TBL] [Abstract][Full Text] [Related]
3. Fluorodeoxyglucose uptake in the bone marrow after granulocyte colony-stimulating factor administration in patients with non-Hodgkin's lymphoma. Hanaoka K; Hosono M; Usami K; Tatsumi Y; Yamazoe Y; Komeya Y; Tsuchiya N; Ishii K; Sumita M Nucl Med Commun; 2011 Aug; 32(8):678-83. PubMed ID: 21499162 [TBL] [Abstract][Full Text] [Related]
4. Obscured bone metastases after administration of hematopoietic factor on FDG-PET. Chhabra A; Batra K; Makler PT Clin Nucl Med; 2006 Jun; 31(6):328-30. PubMed ID: 16714890 [TBL] [Abstract][Full Text] [Related]
5. Effect of colony-stimulating factor and conventional- or high-dose chemotherapy on FDG uptake in bone marrow. Kazama T; Swanston N; Podoloff DA; Macapinlac HA Eur J Nucl Med Mol Imaging; 2005 Dec; 32(12):1406-11. PubMed ID: 16133379 [TBL] [Abstract][Full Text] [Related]
6. Interaction of colony-stimulating factors and fluorodeoxyglucose f(18) positron emission tomography. Mayer D; Bednarczyk EM Ann Pharmacother; 2002 Nov; 36(11):1796-9. PubMed ID: 12398579 [TBL] [Abstract][Full Text] [Related]
7. Diffuse bone marrow involvement of Hodgkin lymphoma mimics hematopoietic cytokine-mediated FDG uptake on FDG PET imaging. Chiang SB; Rebenstock A; Guan L; Alavi A; Zhuang H Clin Nucl Med; 2003 Aug; 28(8):674-6. PubMed ID: 12897658 [TBL] [Abstract][Full Text] [Related]
8. Diffuse bone marrow uptake on whole-body F-18 fluorodeoxyglucose positron emission tomography in a patient taking recombinant erythropoietin. Blodgett TM; Ames JT; Torok FS; McCook BM; Meltzer CC Clin Nucl Med; 2004 Mar; 29(3):161-3. PubMed ID: 15162984 [TBL] [Abstract][Full Text] [Related]
9. Correlations between 18F-FDG uptake by bone marrow and hematological parameters: measurements by PET/CT. Murata Y; Kubota K; Yukihiro M; Ito K; Watanabe H; Shibuya H Nucl Med Biol; 2006 Nov; 33(8):999-1004. PubMed ID: 17127173 [TBL] [Abstract][Full Text] [Related]
10. (18)F-FDG-PET/CT findings of granulocyte colony stimulating factor (G-CSF)-producing lung tumors. Morooka M; Kubota K; Murata Y; Shibuya H; Ito K; Mochizuki M; Akashi T; Chiba T; Nomura T; Ito H; Morita T Ann Nucl Med; 2008 Aug; 22(7):635-9. PubMed ID: 18756367 [TBL] [Abstract][Full Text] [Related]
12. G-CSF induces focal intense bone marrow FDG uptake mimicking multiple bone metastases from uterine cervical cancer: a case report and review of the literature. Mabuchi S; Morimoto A; Fujita M; Isohashi K; Kimura T Eur J Gynaecol Oncol; 2012; 33(3):316-7. PubMed ID: 22873109 [TBL] [Abstract][Full Text] [Related]
13. Optimizing the interval between G-CSF therapy and F-18 FDG PET imaging in children and young adults receiving chemotherapy for sarcoma. Trout AT; Sharp SE; Turpin BK; Zhang B; Gelfand MJ Pediatr Radiol; 2015 Jul; 45(7):1001-6. PubMed ID: 25646737 [TBL] [Abstract][Full Text] [Related]
14. Discordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography. Ak I; Sivrikoz MC; Entok E; Vardareli E Eur J Cardiothorac Surg; 2010 Apr; 37(4):792-6. PubMed ID: 20015657 [TBL] [Abstract][Full Text] [Related]
15. Prevalence and patterns of bone metastases detected with positron emission tomography using F-18 FDG. Nakamoto Y; Osman M; Wahl RL Clin Nucl Med; 2003 Apr; 28(4):302-7. PubMed ID: 12642709 [TBL] [Abstract][Full Text] [Related]
16. Diffuse bone marrow uptake on F-18 FDG PET in patients with myelodysplastic syndromes. Inoue K; Okada K; Harigae H; Taki Y; Goto R; Kinomura S; Kato S; Kaneta T; Fukuda H Clin Nucl Med; 2006 Nov; 31(11):721-3. PubMed ID: 17053396 [TBL] [Abstract][Full Text] [Related]
17. Combined increased and decreased skeletal uptake of F-18 FDG. Goshen E; Davidson T; Yeshurun M; Zwas ST Clin Nucl Med; 2006 Sep; 31(9):520-2. PubMed ID: 16921273 [TBL] [Abstract][Full Text] [Related]
18. Hematopoietic cytokine-mediated FDG uptake simulates the appearance of diffuse metastatic disease on whole-body PET imaging. Hollinger EF; Alibazoglu H; Ali A; Green A; Lamonica G Clin Nucl Med; 1998 Feb; 23(2):93-8. PubMed ID: 9481497 [TBL] [Abstract][Full Text] [Related]